TABLE 3.
Enrichment time (h) | mLAM antibiotica | Composite sensitivity (%) |
P value | |
---|---|---|---|---|
Sponge site | Swab site | |||
Upper arm and/or thigh | Nostril and/or buccal mucosa | |||
1 | ATM | 43.5 | 50.0 | 0.49 |
CAZ | 37.0 | 50.0 | 0.13 | |
24 | ATM | 89.1 | 56.5 | 0.0006 |
CAZ | 89.1 | 58.7 | 0.001 | |
Upper arm and/or thigh | Nostril and/or groin | |||
1 | ATM | 44.4 | 42.2 | 0.80 |
CAZ | 37.8 | 42.2 | 0.56 | |
24 | ATM | 88.9 | 64.4 | 0.002 |
CAZ | 88.9 | 66.7 | 0.004 | |
Upper arm and/or thigh | Buccal mucosa and/or groin | |||
1 | ATM | 44.4 | 53.3 | 0.35 |
CAZ | 37.8 | 51.1 | 0.11 | |
24 | ATM | 88.9 | 73.3 | 0.052 |
CAZ | 88.9 | 77.8 | 0.13 |
ATM, aztreonam; CAZ, ceftazidime.